Vol. 9 No. 4 (2012): Volume 9 issue 4 2012

Articles

• Genetic Analysis of Type 1 Diabetes: Embryonic Stem Cells as New Tools to Unlock Biological Mechanisms in Type 1 Diabetes

  Nick Holmes, Anne Cooke

  • pdf

• Pathogenic Mechanisms in Type 1 Diabetes: The Islet is Both Target and Driver of Disease

  Kate L. Graham, Stuart I. Mannering, Yuxing Zhao, Jonathan Chee, Balasubramanian Krishnamurthy, Helen E. Thomas, Robyn M. Sutherland, Andrew M. Lew, Thomas W.H. Kay

  • pdf

• Comparative Genetics: Synergizing Human and NOD Mouse Studies for Identifying Genetic Causation of Type 1 Diabetes

  John P. Driver, Yi-Guang Chen, Clayton E. Mathews

  • pdf

• Protein Tyrosine Phosphatases and Type 1 Diabetes: Genetic and Functional Implications of PTPN2 and PTPN22

  Karen Cerosaletti and Jane H. Buckner

  • pdf

• From Markers to Molecular Mechanisms: Type 1 Diabetes in the Post-GWAS Era

  Alan G. Baxter and Margaret A. Jordan

  • pdf

• Novel Biomarkers in Type 1 Diabetes

  Yulan Jin, Jin-Xiong She

  • pdf

• Metabolomics in the Studies of Islet Autoimmunity and Type 1 Diabetes

  Matej Oresic

  • pdf

• Gut Microbiota and Type 1 Diabetes

  Outi Vaarala

  • pdf

• Virus Infections as Potential Targets of Preventive Treatments for Type 1 Diabetes

  Noora Nurminen , Sami Oikarinen, Heikki Hyöty

  • pdf

• Helminth Infection and Type 1 Diabetes

  Paola Zaccone and Samuel W. Hall

  • pdf

• Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes

  F. Susan Wong, Li Wen

  • pdf

• Targeted Antigen Delivery to DEC-205+ Dendritic Cells for Tolerogenic Vaccination

  Cathleen Petzold, Sonja Schallenberg, Joel N.H. Stern, Karsten Kretschmer

  • pdf

• Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes

  Suchitra Prasad, Dan Xu, Stephen D. Miller

  • pdf

• Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes

  Ken T. Coppieters, Birgit Sehested Hansen, Matthias G. von Herrath

  • pdf

• Interleukin-1 Antagonists and Other Cytokine Blockade Strategies for Type 1 Diabetes

  Thomas Mandrup-Poulsen

  • pdf

• In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes

  Valentina Di Caro, Nick Giannoukakis, Massimo Trucco

  • pdf

• Immune-Directed Therapy for Type 1 Diabetes at the Clinical Level: The Immune Tolerance Network (ITN) Experience

  Mario R. Ehlers, Gerald T. Nepom

  • pdf

• CD3 Monoclonal Antibodies: A First Step Towards Operational Immune Tolerance in the Clinic

  Lucienne Chatenoud, Herman Waldmann

  • pdf

• Islet Transplantation in Type 1 Diabetes: Ongoing Challenges, Refined Procedures, and Long-Term Outcome

  A.M. James Shapiro

  • pdf

• Islet Neogenesis: A Possible Pathway for Beta-Cell Replenishment

  Susan Bonner-Weir, Lili Guo, Wan-Chun Li, Limor Ouziel-Yahalom, Philippe A. Lysy, Gordon C. Weir, Arun Sharma

  • pdf